EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Incidence of RSV‐ and Influenza‐Associated Hospitalizations With Community‐Acquired Pneumonia and Other Acute Respiratory Infection Among Adults in Japan in 2022–2024: APSG‐J2 Study

Haruka Maeda iD, Shingo Masuda, Bhim Gopal Dhoubhadel, Yuka Fujita, Yuji Akiba, Yutaka Nishigaki, Kei Nakashima, Hiroyuki Ito, Masayuki Nogi, Yoshihito Otsuka, Masayuki Ishida, Eiji Takeuchi iD und 13 weitere

Influenza and Other Respiratory Viruses · 2026

DOI: 10.1111/irv.70238 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Influenza and Other Respiratory Viruses, 2026. Verfasst von Haruka Maeda und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Infections, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan. Hauptthemen laut MEDLINE: Community-Acquired Pneumonia, Hospitalization, Influenza, Human, Respiratory Syncytial Virus Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Quantifying the burden of respiratory syncytial virus (RSV) in adults is challenging compared to influenza, and data among older adults remain scarce in Japan. Country‐specific evidence is essential to support RSV vaccination policy.

Methods

This prospective, multicenter study (APSG‐J2) targeted hospitalized adults with community‐acquired pneumonia (CAP) and other acute respiratory infections (ARI) in seven community hospitals across four catchment areas in Japan between September 2022 and August 2024. Respiratory samples were analyzed using a multiplex polymerase chain reaction (PCR) kit to detect RSV and influenza. Incidence rates of RSV‐ and influenza‐associated hospitalizations were estimated using study data and national statistics, stratified by age and region.

Results

Among 3047 hospitalized patients with CAP/ARI, 1499 (49.2%) underwent multiplex PCR testing. RSV and influenza were detected in 2.8% and 3.3% of tested patients, respectively. The incidences of RSV‐associated CAP/ARI hospitalizations among adults aged ≥ 65 years were 29 and 36 per 100,000 person‐years in the first and second years, respectively, with higher incidences among those aged ≥ 85 years (150 and 131 per 100,000 person‐years). Influenza incidence increased markedly in the second year (from 11 to 71 per 100,000 person‐years for adults age ≥ 65 years), possibly reflecting post‐COVID‐19 transmission changes.

Conclusions

In this multicenter study, we estimated the incidence of RSV‐ and influenza‐associated hospitalizations among adults in Japan. The findings indicated that the incidence increased with age, and influenza‐associated hospitalizations increased in the second year. Continued surveillance is essential to accurately assess RSV burden in the adult population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Community-Acquired PneumoniaHospitalizationInfluenza, HumanRespiratory Syncytial Virus InfectionsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedYoung AdultIncidenceJapanProspective StudiesRespiratory Syncytial Virus, Human

Stichwörter der Autor:innen

Japanadultcommunity‐acquired pneumoniainfluenzarespiratory syncytial virus

Autor:innen und Institutionen

  • Department of Respiratory Infections, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
  • Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
  • Department of Respiratory Medicine, National Hospital Organization Asahikawa Medical Center, Asahikawa, Japan.
  • Department of Respiratory Medicine, Asahikawa-Kosei General Hospital, Asahikawa, Japan.
  • Department of Pulmonology, Kameda Medical Center, Kamogawa, Japan.
  • Department of General Internal Medicine, Kameda Medical Center, Kamogawa, Japan.

ORCID-Profile: Haruka Maeda, Eiji Takeuchi

Förderung

  • Pfizer

Zitieren

APA

Maeda, H., Masuda, S., Dhoubhadel, B. G., Fujita, Y., Akiba, Y., Nishigaki, Y., Nakashima, K., Ito, H., Nogi, M., Otsuka, Y., Ishida, M., Takeuchi, E., Asoh, N., Sawai, T., Hayakawa, K., Dunne, E. M., Schwarz, C., Gessner, B. D., Begier, E., …, & Adult Pneumonia Study Group‐Japan 2 (APSG‐J2) (2026). Incidence of RSV‐ and Influenza‐Associated Hospitalizations With Community‐Acquired Pneumonia and Other Acute Respiratory Infection Among Adults in Japan in 2022–2024: APSG‐J2 Study. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.70238

Vancouver

Maeda H, Masuda S, Dhoubhadel BG, Fujita Y, Akiba Y, Nishigaki Y, et al. Incidence of RSV‐ and Influenza‐Associated Hospitalizations With Community‐Acquired Pneumonia and Other Acute Respiratory Infection Among Adults in Japan in 2022–2024: APSG‐J2 Study. Influenza and Other Respiratory Viruses. 2026. doi:10.1111/irv.70238

BibTeX
@article{Maeda2026,
  author = {Maeda, Haruka and Masuda, Shingo and Dhoubhadel, Bhim Gopal and Fujita, Yuka and Akiba, Yuji and Nishigaki, Yutaka and Nakashima, Kei and Ito, Hiroyuki and Nogi, Masayuki and Otsuka, Yoshihito and Ishida, Masayuki and Takeuchi, Eiji and Asoh, Norichika and Sawai, Toyomitsu and Hayakawa, Koichi and Dunne, Eileen M and Schwarz, Claudia and Gessner, Bradford D and Begier, Elizabeth and Ito, Shuhei and Igarashi, Ataru and Osanai, Shinobu and Morimoto, Konosuke and Ariyoshi, Koya and Adult Pneumonia Study Group‐Japan 2 (APSG‐J2), Adult Pneumonia Study Group‐Japan 2 (APSG‐J2)},
  title = {Incidence of RSV‐ and Influenza‐Associated Hospitalizations With Community‐Acquired Pneumonia and Other Acute Respiratory Infection Among Adults in Japan in 2022–2024: APSG‐J2 Study},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2026},
  doi = {10.1111/irv.70238}
}
Kostenlos starten →